M. Delcroix (Leuven, Belgium), S. Adnot (Creteil, France)
Magnetic resonance in pulmonary arterial hypertension: a noninvasive alternative in the assessment of right ventricular function
J. Morales-Blanhir, J. A. Barbera, T. M. Caralt, J. L Valera, T. Melgosa, A. Fabiano, J. Roca, R. Rodriguez-Roisin (Barcelona, Spain)
|  |
Assessment of dynamic changes in perfusion lung scintigrams of patients with CTEPH
N. Skoro-Sajer, A. Becherer, W. Klepetko, M. P. Kneussl, I. M. Lang (Vienna, Austria)
| |
Effect of mitochondrial inhibitors and uncouplers on hypoxic pulmonary vasoconstriction
N. Weissmann, N. Ebert, L. Bader, J. Conzen, H. A. Ghofrani, R. T. Schermuly, L. Fink, J. Hänze, F. Rose, R. Voswinckel, W. Seeger, F. Grimminger (Giessen, Germany)
| |
Endothelium-dependent relaxation and hypoxic pulmonary vascular response in isolated pulmonary arteries of endothelial nitric oxide synthase-deficient mice
L. Jiang, M. Cauberghs, S. Janssens, M. Demedts, M. Delcroix (Leuven, Belgium)
| |
Pulmonary artery pressure (PAP) is reduced by inhaled sodium nitroprusside (SNP) in an isolated lung model of pulmonary hypertension: comparison with systemic application
H. Wahn, F. Finter, H. Kaufmann, G. Ertl, M. Schmidt (Würzburg, Germany)
| |
Hyperplasia of pulmonary artery smooth muscle cells in primary and secondary pulmonary hypertension is causally related to serotonin transporter overexpression
S. Eddahibi, M. Humbert, E. Fadel, B. Raffestin, G. Simonneau, M. Hamon, S. Adnot (Créteil, France)
| |
Polymorphism of prostacyclin synthase gene in pulmonary hypertension
K. Tatsumi, S. Amano, N. Tanabe, Y. Kasahara, K. Kurosu, H. Igari, Y. Takiguchi, Y. Kasuya, S. Kimura, T. Kuriyama (Chiba, Japan)
| |
Decrease in circulating monocyte metalloproteinase-9 content with increasing severity of pulmonary hypertension
C. Cantini, P. Kieffer, F. Schrijen, P. Malvestio, J. M. Polu, I. Lartaud-Idjouadiène, J. Atkinson, F. Chabot (Nancy, Vandoeuvre-les-Nancy, France)
| |